What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?

Learning objective:

After participating in this webinar, viewers should be able to:

• Explain what the key drivers are when selecting RRMM patients for treatment with CAR T-cell therapy

Faculty:

• Michel Delforge (Belgium)
• Joaquin Martinez-Lopez (Spain)
• Herman Einsele (Germany)